Vaxinano in Brazil
Tuesday, June 07th 2022
Vaxinano is making headlines in Brazil for the development of its vaccine against toxoplasmosis in cats.
Vaxinano is part of the one health objective to protect the environment, animals and people against this parasitosis, which is a public health problem.
We are delighted to collaborate with the Universidade do Estado de Santa Catarina and Pr. Andreas Lazaros.
In Brazil, in certain areas, ocular toxoplasmosis can reach 10% of the population. There is, to date, no treatment or vaccine.